Improving Care in Paediatric Patients with NF1-PN

In this CME accredited online course, you will hear from international experts about treatment of PN caused by NF1 with a special focus on MEK inhibitors.

Learning Objectives:

• MEK inhibitors in children, adolescents, and young adult with PN: results of clinical trials and real-world experience.
• Identifying candidates for MEK inhibitors: who and when?
• Is there a minimum age for MEK inhibition?
• How long should we treat, potential for alternative schedules?
• Managing side effects of MEK inhibitors. 
  Supported by an unrestricted educational grant from Alexion AstraZeneca Rare Diseases.

Approved Credit: 1 hour(s) CME

Access course here.

For technical issues, please contact our team at info@siop-online.org